Unique features of central neuropathic pain in multiple sclerosis: Results of a cluster analysis

被引:11
|
作者
Rivel, Michal [1 ,2 ]
Achiron, Anat [2 ,3 ,4 ]
Dolev, Mark [3 ]
Stern, Yael [3 ]
Zeilig, Gabi [4 ,5 ]
Defrin, Ruth [1 ,2 ]
机构
[1] Tel Aviv Univ, Sackler Fac Med, Sch Hlth Profess, Dept Phys Therapy, Tel Aviv, Israel
[2] Tel Aviv Univ, Sagol Sch Neurosci, Tel Aviv, Israel
[3] Sheba Med Ctr, Multiple Sclerosis Ctr, Tel Hashomer, Israel
[4] Tel Aviv Univ, Sackler Fac Med, Tel Aviv, Israel
[5] Sheba Med Ctr, Dept Neurol Rehabil, Tel Hashomer, Israel
关键词
QUALITY-OF-LIFE; CENTRAL SENSITIZATION; OFFSET ANALGESIA; PREVALENCE; MODULATION; MECHANISMS; QUESTIONNAIRE; METAANALYSIS; SEVERITY;
D O I
10.1002/ejp.1934
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background Central neuropathic pain (CNP) is an excruciating condition, prevalent in up to a third of patients with multiple sclerosis (MS). Identifying CNP among MS patients is particularly challenging considering the ample comorbid chronic pain conditions and sensory disturbances entailed by the disease. The aim was to identify sensory features unique to CNP beyond those of chronic pain and MS. Methods Participants were 112 MS patients: 44 with a diagnosis of CNP, 28 with a diagnosis of chronic musculoskeletal pain (MSP), and 40 pain free. Participants underwent testing of thermal and mechanical thresholds, thermal grill illusion (TGI), pain adaptation (PA), and offset analgesia (OA), and chronic pain was characterized. A two-step cluster analysis was performed, and the association between the cluster membership and the clinical group membership (CNP, MSP, pain free) was evaluated. Results The CNP and MSP groups were similar in most of the chronic pain variables (e.g., severity, location and quality) and MS-related variables (e.g., type, severity and medication intake). The three created clusters had unique sensory features: (1) 'Hyposensitivity' (increased thermal and touch thresholds) characterized the CNP group; (2) 'Poor inhibition and hyperalgesia' (worst PA and OA and decreased TGI threshold) characterized the MSP group; and (3) 'Efficient inhibition' (best PA and OA, smallest sensory loss) characterized the pain-free group. Conclusions The unique sensory features of CNP and MSP provide insight into their pathophysiology, and evaluating them may increase the ability to provide individually based interventions. Efficient inhibition may protect MS patients from chronic pain. Significance Cluster analysis among patients with multiple sclerosis (MS) revealed that while central neuropathic pain is associated with thermal and mechanical hypoesthesia, musculoskeletal pain is involved with reduced pain inhibition and hyperalgesia; sensory profiles that provide insights into the mechanisms of these conditions and may promote an individually based pain management.
引用
收藏
页码:1107 / 1122
页数:16
相关论文
共 50 条
  • [31] Central pain in multiple sclerosis - Sensory abnormalities
    Osterberg, A.
    Boivie, J.
    EUROPEAN JOURNAL OF PAIN, 2010, 14 (01) : 104 - 110
  • [32] Meta-analysis of cannabis based treatments for neuropathic and multiple sclerosis-related pain
    Iskedjian, Michael
    Bereza, Basil
    Gordon, Allan
    Piwko, Charles
    Einarson, Thomas R.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (01) : 17 - 24
  • [33] Double blind, randomised placebo controlled, crossover trial of topiramate in central neuropathic pain due to multiple sclerosis
    Rog, DJ
    Young, CA
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2003, 74 (10): : 1457 - 1457
  • [34] Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain
    Nemat Khan
    Andy Kuo
    David A. Brockman
    Matthew A. Cooper
    Maree T. Smith
    Inflammopharmacology, 2018, 26 : 77 - 86
  • [35] Pharmacological inhibition of the NLRP3 inflammasome as a potential target for multiple sclerosis induced central neuropathic pain
    Khan, Nemat
    Kuo, Andy
    Brockman, David A.
    Cooper, Matthew A.
    Smith, Maree T.
    INFLAMMOPHARMACOLOGY, 2018, 26 (01) : 77 - 86
  • [36] Cluster headache-like pain in multiple sclerosis
    Leandri, M
    Cruccu, G
    Gottlieb, A
    CEPHALALGIA, 1999, 19 (08) : 732 - 734
  • [37] Neuropathic Pain in Multiple Sclerosis Improved With Oral Famciclovir: A Case Report
    Emeriewen, Krisztina
    Macgregor, Cheryl
    Athanasiadis, Yannis
    Tsatsos, Michael
    OPHTHALMIC PLASTIC AND RECONSTRUCTIVE SURGERY, 2016, 32 (05): : E119 - E121
  • [38] Neuropathic pain in multiple sclerosis: serum biomarkers and MRI lesion localization
    Mohamed Hamdy Ismail
    Amal SE ELmotayam
    Sara F. Saadawy
    Rabab M. Elfwakhry
    Hebatallah M. Fawzy
    Noha T. Sarhan
    The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, 61 (1)
  • [39] Comparison of Neuropathic Pain in Neuromyelitis Optica Spectrum Disorder and Multiple Sclerosis
    Hyun, Jae-Won
    Jang, Hyunmin
    Yu, JaeBin
    Park, Na Young
    Kim, Su-Hyun
    Huh, So-Young
    Kim, Woojun
    Park, Min Su
    Oh, Jeeyoung
    Park, Kee Duk
    Kim, Ho Jin
    JOURNAL OF CLINICAL NEUROLOGY, 2020, 16 (01): : 124 - 130
  • [40] Spinal Microglia Maintain Multiple Sclerosis-Associated Neuropathic Pain
    Lamerand, Sydney R.
    Anumolu, Anvita
    Jain, Ridhima
    Steber, Skyy
    Deshpande, Ronit
    Taylor, Bradley K.
    JOURNAL OF PAIN, 2024, 25 (04): : 22 - 22